Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Jazz Pharmaceuticals PLC    JAZZ   IE00B4Q5ZN47

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Jazz Pharmaceuticals PLC
Operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products.

It has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd on January 18, 2012 and is headquartered in Dublin, Ireland.

Number of employees : 910 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmaceutical Products1,173100%1,325100% +12.95%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States1,00785.9%1,19390% +18.41%
Europe126.7210.8%103.617.8% -18.23%
All Other38.763.3%28.312.1% -26.97%
Managers
NameAgeSinceTitle
Bruce C. Cozadd, MBA522012Chairman & Chief Executive Officer
Russell J. Cox532012Chief Operating Officer & Executive Vice President
Matthew P. Young, MBA472013Chief Financial Officer & Executive Vice President
Karen L. Smith MD, PhD482015Chief Medical Officer, Global Head-R&D
Paul L. Berns492010Independent Class II Director
Patrick G. Enright, MBA542012Independent Director
Seamus C. Mulligan552012Independent Director
Ken W. O'Keefe, MBA492012Independent Director
Rick E. Winningham, MBA562012Lead Independent Director
Catherine Angell Sohn, PhD622012Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 59,892,335 58,493,891 97.7% 0 0.0% 97.7%
Shareholders
NameEquities%
Fidelity Management & Research Co. 8,703,053 14.4%
Putnam Investment Management LLC 7,564,438 12.5%
The Vanguard Group, Inc. 4,289,739 7.09%
BlackRock Fund Advisors 2,109,973 3.49%
FIL Investment Advisors (UK) Ltd 1,798,486 2.97%
Westfield Capital Management Co. LP 1,637,937 2.71%
Cadian Capital Management LP 1,311,292 2.17%
Partner Fund Management LP 1,182,693 1.95%
Seamus C. Mulligan 1,048,008 1.73%
Janus Capital Management LLC 977,224 1.61%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Specialty & Advanced Pharmaceuticals
Advertisement
Sector Specialty & Advanced Pharmaceuticals
1st jan.Capitalization (M$)
JAZZ PHARMACEUTICALS P..-27.58%6 097
ABBVIE INC2.80%98 969
MERCK KGAA2.65%12 712
KYOWA HAKKO KIRIN CO L..-18.37%7 648
MALLINCKRODT PLC-29.85%5 542
ZHANGZHOU PIENTZEHUANG..1.57%4 078
INDIVIOR PLC57.56%2 679
YUHAN CORPORATION--.--%1 885
MAYNE PHARMA GROUP LTD9.82%1 599
THERAPEUTICSMD INC-32.88%1 211
EAGLE PHARMACEUTICALS ..-13.65%1 182
ADVANCED ACCELERATOR A..--.--%1 174
AIMMUNE THERAPEUTICS I..25.15%1 156
SUPERNUS PHARMACEUTICA..65.92%1 104
REPLIGEN CORPORATION12.12%1 073
KNIGHT THERAPEUTICS IN..29.87%1 005
LG LIFE SCIENCES, LTD--.--%920
NICHI-IKO PHARMACEUTIC..-46.02%838
STALLERGENES GREER-8.25%620
RECIPHARM AB (PUBL)6.01%619
DONG-A ST CO LTD--.--%588
Sector Specialty & Advanced Pharmaceuticals
Jazz Pharmaceuticals PLC : Connections
Jazz Pharmaceuticals Plc
Connaught House
One Burlington Road
4th Floor
Dublin 4

Phone : +353.1.634.7800
Fax : +353.1.634.7850
Web : www.jazzpharma.com
© 2016 People , Fundamentals and Ownership